Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

3 Things You Need to Know from Keryx's Stifel Conference Presentation
Motley Fool
Saturday, September 14, 2013 - 11:02am
tags:
Keryx, chronic kidney disease, dialysis, hyperphosphatemia, Zerenex
3 Horrendous Health-Care Stocks This Week
Motley Fool
Saturday, September 14, 2013 - 11:01am
tags:
Neurocrine Biosciences, ChemoCentryx, GSK, Avanir
1 Drug Dramatically Reshaping Pancreatic Cancer Treatment
Motley Fool
Saturday, September 14, 2013 - 11:00am
tags:
Celgene Corporation, Abraxane, pancreatic cancer
3 Promising Stocks Targeting CTGF and Dermal Scarring
Wall St Cheat Sheet
Saturday, September 14, 2013 - 10:56am
tags:
dermal scarring, RXI-109, Alnylam, Pfizer, RXi Pharmaceuticals, EXC-001, ALN-TTR02
Unilife Strutting Over Sanofi Deal (video)
The Street
Saturday, September 14, 2013 - 10:53am
tags:
Unilife, Sanofi
Lixisenatide NDA Withdrawn by Sanofi
Yahoo/Zacks
Saturday, September 14, 2013 - 10:52am
tags:
lixisenatide, Sanofi, type 2 diabetes, diabetes
3 Humongous Health-Care Stocks This Week
Motley Fool
Saturday, September 14, 2013 - 10:50am
tags:
Geron, Aratana, Kythera Biopharmaceuticals
Fallout From This Heart-Drug Failure
Motley Fool
Saturday, September 14, 2013 - 10:49am
tags:
Amgen, Omecamtiv Mecarbil, heart failure, Cytokinetics
Is Vivus a Rudderless Ship?
Motley Fool
Saturday, September 14, 2013 - 10:47am
tags:
Vivus, Qsymia, Arena Pharmaceuticals, Belviq, obesity, weight loss
Gilead Investors' Nightmare Scenario
Motley Fool
Saturday, September 14, 2013 - 10:45am
tags:
Gilead Sciences
4 Healthcare Stock Stories Making a Buzz On Friday
Wall St Cheat Sheet
Saturday, September 14, 2013 - 10:44am
tags:
Teva Pharmaceuticals, Ariad Pharmaceuticals, Alexion, Galena Biopharma
Data from Alexion's Soliris Study
Yahoo/Zacks
Saturday, September 14, 2013 - 10:41am
tags:
Alexion, acute antibody-mediated rejection, kidney transplants, transplant, Soliris
Regeneron Pharma Soars As Sanofi Mulls Doubling Stake
investors.com
Saturday, September 14, 2013 - 10:39am
tags:
Regeneron, Sanofi
Top Biotech Stock Picks for Q4 2013: An Interview with the Senior Analyst at Oppenheimer & Company
Yahoo/Wall St Transcript
Saturday, September 14, 2013 - 10:38am
tags:
Amgen, Celgene, ONYX Pharmaceuticals, Keryx, Pluristem Therapeutics, NPS Pharmaceuticals
Can This Biotech Star Deliver for Dividend Investors?
Motley Fool
Saturday, September 14, 2013 - 10:35am
tags:
Amgen
3 Key Takeaways From Isis' Investor Roadshow Week
Motley Fool
Friday, September 13, 2013 - 3:50pm
tags:
Isis Pharmaceuticals, ISIS-APOCIIIRx, Biogen Idec
Astex Sued by Shareholder Over $886 Million Otsuka Bid
Bloomberg
Friday, September 13, 2013 - 3:44pm
tags:
Astex, shareholders, Otsuka, M&A
Bayer AG comes under investigation in China
Yahoo/AP
Friday, September 13, 2013 - 3:44pm
tags:
Bayer AG, China
Lilly files $500 million lawsuit against Canada
Fierce Pharma
Friday, September 13, 2013 - 9:18am
tags:
Canada, Eli Lilly, patents
Actavis, Gilead, Valeant: Outlook For Health Stocks
Investors.com
Friday, September 13, 2013 - 9:16am
tags:
Valeant Pharmaceuticals, Actavis, Gilead

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.